Hypoxia is a driver of aggressive tumor behavior, but the mechanisms are not completely understood. In a global phosphoproteomics screen, we now demonstrate that hypoxia induces the recruitment of Akt2 to tumor mitochondria, and Akt phosphorylation of pyruvate dehydrogenase kinase (PDK1) on Thr346. In turn, Akt-phosphorylated PDK1 shuts off oxidative phosphorylation via phosphorylation of the pyruvate dehydrogenase complex, and reprograms tumor metabolism towards glycolysis. Akt-phosphorylation of PDK1 is required to prevent autophagy, maintain cell viability and support tumor cell proliferation in hypoxia, in vivo. Therefore, mitochondrial Akt is a pathophysiologic switch for tumor adaptation in hypoxia.
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: LC-MS/MS ; SILAC ; Phosphoproteome ; Akt ; Mitochondria
Principal Investigators: (in alphabetical order) |
Dario C. Altieri |
Submitting User: | tangh |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
![]() |
||
Biological Replicates:
![]() |
||
Technical Replicates:
![]() |
||
Identification Results | ||
Proteins (Human, Remapped):
![]() |
||
Proteins (Reported):
![]() |
||
Peptides:
![]() |
||
Variant Peptides:
![]() |
||
PSMs:
![]() |
||
Quantification Results | ||
Differential Proteins:
![]() |
||
Quantified Proteins:
![]() |
||
Browse Dataset Files | |
FTP Download Link (click to copy):
|